Karamedica

Karamedica specializes in expanding medical and veterinary applications of biopolymer-based products, particularly those containing chitosan, through innovative decontamination processes. The company has developed patented non-thermal plasma technology to safely decontaminate delicate biomaterials, overcoming limitations of traditional sterilizatio... n methods. Their focus includes creating implantable hemostatic devices for surgical bleeding control and drug delivery systems for conditions like superficial bladder cancer and cerebral amyloid angiopathy. By leveraging chitosan's unique properties, Karamedica aims to enhance its clinical applications in various medical fields.Read More